84 related articles for article (PubMed ID: 21703011)
41. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.
Allavena P; Sica A; Solinas G; Porta C; Mantovani A
Crit Rev Oncol Hematol; 2008 Apr; 66(1):1-9. PubMed ID: 17913510
[TBL] [Abstract][Full Text] [Related]
42. Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like action.
Ishiguro H; Ishiguro Y; Kubota Y; Uemura H
Prostate; 2007 Jun; 67(9):924-32. PubMed ID: 17440964
[TBL] [Abstract][Full Text] [Related]
43. Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases.
Neo JH; Malcontenti-Wilson C; Muralidharan V; Christophi C
J Gastroenterol Hepatol; 2007 Apr; 22(4):577-84. PubMed ID: 17376054
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2.
Menon J; Soto-Pantoja DR; Callahan MF; Cline JM; Ferrario CM; Tallant EA; Gallagher PE
Cancer Res; 2007 Mar; 67(6):2809-15. PubMed ID: 17363603
[TBL] [Abstract][Full Text] [Related]
45. Angiotensin-(1-7) and the renin-angiotensin system.
Santos RA; Ferreira AJ
Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):122-8. PubMed ID: 17293687
[TBL] [Abstract][Full Text] [Related]
46. Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer.
Kosaka T; Miyajima A; Takayama E; Kikuchi E; Nakashima J; Ohigashi T; Asano T; Sakamoto M; Okita H; Murai M; Hayakawa M
Prostate; 2007 Jan; 67(1):41-9. PubMed ID: 17044086
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical detection of angiotensin receptors AT1 and AT2 in normal rat pituitary gland, estrogen-induced rat pituitary tumor and human pituitary adenomas.
Pawlikowski M
Folia Histochem Cytobiol; 2006; 44(3):173-7. PubMed ID: 16977796
[TBL] [Abstract][Full Text] [Related]
48. Resection of colorectal liver metastases: current perspectives.
McLoughlin JM; Jensen EH; Malafa M
Cancer Control; 2006 Jan; 13(1):32-41. PubMed ID: 16508624
[TBL] [Abstract][Full Text] [Related]
49. Opposing actions of angiotensin II type 1 and 2 receptors on plasma cholesterol levels in rats.
Hirano T; Ran J; Adachi M
J Hypertens; 2006 Jan; 24(1):103-8. PubMed ID: 16331107
[TBL] [Abstract][Full Text] [Related]
50. Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2.
Zhang Y; Griendling KK; Dikalova A; Owens GK; Taylor WR
Hypertension; 2005 Oct; 46(4):732-7. PubMed ID: 16172434
[TBL] [Abstract][Full Text] [Related]
51. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.
Hunyady L; Catt KJ
Mol Endocrinol; 2006 May; 20(5):953-70. PubMed ID: 16141358
[TBL] [Abstract][Full Text] [Related]
52. Angiotensin receptors: a new role in cancer?
Deshayes F; Nahmias C
Trends Endocrinol Metab; 2005 Sep; 16(7):293-9. PubMed ID: 16061390
[TBL] [Abstract][Full Text] [Related]
53. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of human lung cancer cell growth by angiotensin-(1-7).
Gallagher PE; Tallant EA
Carcinogenesis; 2004 Nov; 25(11):2045-52. PubMed ID: 15284177
[TBL] [Abstract][Full Text] [Related]
55. Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response.
Leung PS; Suen PM; Ip SP; Yip CK; Chen G; Lai PB
Regul Pept; 2003 Nov; 116(1-3):61-9. PubMed ID: 14599716
[TBL] [Abstract][Full Text] [Related]
56. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis.
Fujita M; Hayashi I; Yamashina S; Itoman M; Majima M
Biochem Biophys Res Commun; 2002 Jun; 294(2):441-7. PubMed ID: 12051731
[TBL] [Abstract][Full Text] [Related]
57. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb.
Silvestre JS; Tamarat R; Senbonmatsu T; Icchiki T; Ebrahimian T; Iglarz M; Besnard S; Duriez M; Inagami T; Lévy BI
Circ Res; 2002 May; 90(10):1072-9. PubMed ID: 12039796
[TBL] [Abstract][Full Text] [Related]
58. Perindopril: possible use in cancer therapy.
Yoshiji H; Kuriyama S; Fukui H
Anticancer Drugs; 2002 Mar; 13(3):221-8. PubMed ID: 11984065
[TBL] [Abstract][Full Text] [Related]
59. Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade.
Leenen FH; Yuan B
Hypertension; 2001 Mar; 37(3):981-4. PubMed ID: 11244027
[TBL] [Abstract][Full Text] [Related]
60. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
